Pure Global

Adipose derived mesenchymal stem cells as local treatment of ulcerative colitis - Trial 2022-002325-99

Access comprehensive clinical trial information for 2022-002325-99 through Pure Global AI's free database. This phase not specified trial is sponsored by Aarhus University Hospital and is currently Ongoing. The study focuses on Ulcerative colitis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
2022-002325-99
Ongoing
Trial Details
EU Clinical Trials Register โ€ข 2022-002325-99
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Adipose derived mesenchymal stem cells as local treatment of ulcerative colitis

Study Focus

Ulcerative colitis

Sponsor & Location

Aarhus University Hospital

Innovationsfonden

Timeline & Enrollment

N/A

N/A

N/A

Primary Outcome

Reduceret inflammatorisk aktivitet vurderet med endoskopisk Mayoscore (bilag 1) 14 dage efter behandling med injektion af allogene fedtderiverede mesenkymale stamceller.

ICD-10 Classifications

Ulcerative colitis
Other ulcerative colitis
Ulcerative colitis, unspecified
Arthropathy in ulcerative colitis
Juvenile arthritis in ulcerative colitis

Data Source

EU Clinical Trials Register

2022-002325-99

Non-Device Trial